23,99 €
inkl. MwSt.
Sofort lieferbar
12 °P sammeln
Andere Kunden interessierten sich auch für
![Formulation et évaluation de la metformine et du glimépiride]( "Formulation et évaluation de la metformine et du glimépiride")
Formulation et évaluation de la metformine et du glimépiride23,99 €![Formulazione e valutazione di metformina e glimepiride]( "Formulazione e valutazione di metformina e glimepiride")
Formulazione e valutazione di metformina e glimepiride23,99 €![Effect of antidiabetic agents on hepatic functions in diabetic animals]( "Effect of antidiabetic agents on hepatic functions in diabetic animals")
Effect of antidiabetic agents on hepatic functions in diabetic animals40,99 €![Formulierung und Bewertung von Metformin und Glimepirid]( "Formulierung und Bewertung von Metformin und Glimepirid")
Formulierung und Bewertung von Metformin und Glimepirid35,90 €![Multifunctional Polymeric Excipients for Targeted Drug Delivery]( "Multifunctional Polymeric Excipients for Targeted Drug Delivery")
Multifunctional Polymeric Excipients for Targeted Drug Delivery36,99 €![Sustain Release Matrix Tablet of Cinnarizine]( "Sustain Release Matrix Tablet of Cinnarizine")
Sustain Release Matrix Tablet of Cinnarizine32,99 €![Design and Evaluation of bilayer tablets of Pioglitazone and Metformin]( "Design and Evaluation of bilayer tablets of Pioglitazone and Metformin")
Design and Evaluation of bilayer tablets of Pioglitazone and Metformin38,99 €
The objective of this research was to develop a combined anti-diabetic formulation of two different drugs acting by different mechanism. So they can complement each other and together lower the blood glucose level effectively. Metformin and glimepiride act by different mechanisms. Glimepiride reduce hyper glycaemia by enhancing insulin secretion, whereas metformin acts to improve insulin sensitivity and suppress hepatic glucose output. Because of their complementary mechanism of action, combination therapy with glimepiride and metformin would be rational and may lead to benefits in terms of improved glycaemic control and improved tolerability at lower doses of the individual agents.Sustained drug delivery can improve patient compliance and help in maintaining effective level of blood glucose.